MOD 2 - extend contract end date for one month for KHC - BPA for medtox drug screening supplies for the laboratory dept.
Ended Awarded Last action
- Contract number
- 75H71025F80054
- Awardee
-
Medtox Laboratories Inc. UEI KVP6B95J5TB5
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $0
Award facts
- Contract value 0% obligated
- $26,419.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334515 Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Burlington, NC, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $26,420 |
About this award
The Indian Health Service awarded a delivery order valued at $26,419.76 to Medtox Laboratories Inc. for drug screening supplies supporting the Laboratory Department at a facility in Burlington, North Carolina. This award, finalized on December 31, 2024, represents modifications (MOD 2 and MOD 3) that extend the contract end date through March 31, 2026, each extending the period by one month. The contract employs firm fixed pricing and was awarded without set-aside designation, indicating open competition. Medtox Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings and headquartered in St. Paul, Minnesota, operates as a specialized provider of laboratory testing and diagnostic services with a focus on drug screening solutions.
This delivery order is issued under Medtox's General Services Administration Multiple Award Schedule contract, which serves as the primary vehicle for the company's federal work. The Indian Health Service has consistently partnered with Medtox for drug screening supplies and laboratory services across multiple facilities nationwide, reflecting the company's established capability in providing critical substance abuse screening programs and medical testing resources to federal health agencies. The contract structure and vendor history demonstrate a streamlined procurement approach leveraging the existing GSA schedule framework to support IHS operational laboratory needs.
Quick answers
Who was awarded contract 75H71025F80054?
75H71025F80054 was awarded to Medtox Laboratories Inc. by Indian Health Service (Department of Health and Human Services) on December 31, 2024.
How much is contract 75H71025F80054 worth?
The government has obligated $0 on 75H71025F80054. Its current value, with exercised options, is $26,420.
Is contract 75H71025F80054 an order under another contract?
Yes. 75H71025F80054 is a delivery order under 47QSWA20D007S, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75H71025F80054 competed?
The extent of competition for 75H71025F80054 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award